These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 27266816)

  • 1. Extended lymphadenectomy in elderly and/or highly co-morbid gastric cancer patients: A retrospective multicenter study.
    Rausei S; Ruspi L; Rosa F; Morgagni P; Marrelli D; Cossu A; Cananzi FC; Lomonaco R; Coniglio A; Biondi A; Cipollari C; Graziosi L; Fumagalli U; Casella F; Bertoli P; di Leo A; Alfieri S; Vittimberga G; Roviello F; Orsenigo E; Quagliuolo V; Montemurro S; Baiocchi G; Persiani R; Bencivenga M; Donini A; Rosati R; Sansonetti A; Ansaloni L; Zanoni A; Galli F; Dionigi G;
    Eur J Surg Oncol; 2016 Dec; 42(12):1881-1889. PubMed ID: 27266816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcome after D1 vs D2-3 gastrectomy for treatment of gastric cancer.
    Danielson H; Kokkola A; Kiviluoto T; Sirén J; Louhimo J; Kivilaakso E; Puolakkainen P
    Scand J Surg; 2007; 96(1):35-40. PubMed ID: 17461310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal extent of lymphadenectomy for gastric adenocarcinoma: A 7-institution study of the U.S. gastric cancer collaborative.
    Randle RW; Swords DS; Levine EA; Fino NF; Squires MH; Poultsides G; Fields RC; Bloomston M; Weber SM; Pawlik TM; Jin LX; Spolverato G; Schmidt C; Worhunsky D; Cho CS; Maithel SK; Votanopoulos KI
    J Surg Oncol; 2016 Jun; 113(7):750-5. PubMed ID: 26996496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical outcomes of gastrectomy with D1 lymph node dissection performed for patients with unfavorable clinical conditions.
    Ramos MFKP; Pereira MA; Dias AR; Yagi OK; Zaidan EP; Ribeiro-Júnior U; Zilberstein B; Cecconello I
    Eur J Surg Oncol; 2019 Mar; 45(3):460-465. PubMed ID: 30497814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Total gastrectomy for gastric cancer: can the type of lymphadenectomy condition the long-term results?].
    Di Martino N; Izzo G; Cosenza A; Vicenzo L; Monaco L; Torelli F; Basciotti A; Brillantino A; Marra A
    Suppl Tumori; 2005; 4(3):S84-5. PubMed ID: 16437920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the operative outcomes of D1 and D2 gastrectomy performed at a single Western center with multiple surgeons: a retrospective analysis with propensity score matching.
    Lam S; Tan E; Menezes A; Martin D; Gallagher J; Storey D; Sandroussi C
    World J Surg Oncol; 2018 Jul; 16(1):136. PubMed ID: 29986713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified versus standard D2 lymphadenectomy in total gastrectomy for nonjunctional gastric carcinoma with lymph node metastasis.
    Galizia G; Lieto E; De Vita F; Castellano P; Ferraraccio F; Zamboli A; Mabilia A; Auricchio A; De Sena G; De Stefano L; Cardella F; Barbarisi A; Orditura M
    Surgery; 2015 Feb; 157(2):285-96. PubMed ID: 25532433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
    Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
    J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer.
    Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
    Anticancer Res; 2000; 20(2B):1285-9. PubMed ID: 10810436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
    Ramacciato G; Aurello P; D'Angelo F; Cicchini C; Sternberg CN
    Hepatogastroenterology; 2000; 47(35):1470-4. PubMed ID: 11100379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer.
    Degiuli M; Sasako M; Ponti A; Vendrame A; Tomatis M; Mazza C; Borasi A; Capussotti L; Fronda G; Morino M;
    Br J Surg; 2014 Jan; 101(2):23-31. PubMed ID: 24375296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.
    Songun I; Putter H; Kranenbarg EM; Sasako M; van de Velde CJ
    Lancet Oncol; 2010 May; 11(5):439-49. PubMed ID: 20409751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical and oncological outcomes of D1 versus D2 gastrectomy among elderly patients treated for gastric cancer.
    Back J; Sallinen V; Kokkola A; Puolakkainen P
    Scand J Surg; 2022; 111(2):14574969221096193. PubMed ID: 35611500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resection for gastric cancer in the community.
    van de Velde CJ
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complications of gastrectomy with lymphadenectomy in gastric cancer.
    Zilberstein B; Martins BC; Jacob CE; Bresciani C; Lopasso FP; de Cleva R; Pinto Junior PE; Junior UR; Perez RO; Gama-Rodrigues J
    Gastric Cancer; 2004; 7(4):254-9. PubMed ID: 15616774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extent of lymph node dissection for adenocarcinoma of the stomach.
    Mocellin S; McCulloch P; Kazi H; Gama-Rodrigues JJ; Yuan Y; Nitti D
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD001964. PubMed ID: 26267122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D1 versus D2 Gastrectomy for Gastric Adenocarcinoma.
    Lavy R; Hershkovitz Y; Chikman B; Shapira Z; Poluksht N; Yarom N; Sandbank J; Halevy A
    Isr Med Assoc J; 2015 Dec; 17(12):735-8. PubMed ID: 26897973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of D1 and D2 ganglionic dissection in advanced gastric cancer at Rebagliati Hospital].
    Cornejo C; Portanova M
    Rev Gastroenterol Peru; 2006; 26(4):351-6. PubMed ID: 17211484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified radical lymphadenectomy (D1.5) for T2-3 gastric cancer.
    Ichikura T; Chochi K; Sugasawa H; Mochizuki H
    Langenbecks Arch Surg; 2005 Sep; 390(5):397-402. PubMed ID: 16041552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative adjuvant treatment for gastric cancer improves long-term survival after curative resection and D2 lymphadenectomy. Results from a Latin American Center.
    Norero E; Bustos M; Herrera ME; Cerda J; González P; Ceroni M; Martínez C; Briceño E; Rojas H; Cártes R; Lopez V; Hidalgo V; Báez S; Caracci M; Viñuela E; Díaz A
    Eur J Surg Oncol; 2016 Jan; 42(1):94-102. PubMed ID: 26577767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.